PRTODAY / NewswireToday Free press release distribution service network

More news: Research
Written by / Agency / Source: PathXL

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

PathXL At USCAP - Official US Launch of Powerful Tumor Cell Counting Add-on for TissueMark - In December 2014 PathXL announced a significant upgrade to its award-winning automated tumor annotation and analysis software, TissueMark® - PathXL.com
PathXL At USCAP - Official US Launch of Powerful Tumor Cell Counting Add-on for TissueMark

 

NewswireToday - /newswire/ - London, United Kingdom, 2015/03/19 - In December 2014 PathXL announced a significant upgrade to its award-winning automated tumor annotation and analysis software, TissueMark® - PathXL.com. NYSE: PHG, AEX: PHIA

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Owing to the overwhelming success of the initial announcement, PathXL plan to unveil and demonstrate this powerful TissueMark add-on for cell counting in the US for the first time, during the 104th United States & Canadian Academy of Pathology meeting.

The tumor cell counting capability is an extension to PathXL’s current TissueMark range. TissueMark is designed for the rapid and automated detection and analysis of tumor tissue on digitized H&E stained tissue samples for molecular profiling of solid tumors including next generation sequencing. Tissuemark also has a strong capability in terms of efficiency, accuracy and acceleration of clinical trials that require molecular analysis. As with all of PathXL’s products, the new TissueMark application has been carefully validated against known standards and results show strong concordance with time-consuming manual counts of tumor nuclei across lung, colorectal and breast whole tissue sections

Validation results were first unveiled by PathXL’s founder and VP for R&D, Professor Peter Hamilton at the Digital Pathology Congress in December. Following this meeting, PathXL (pathxl.com) has experienced a significant volume of enquiries and interest in this software which now provides the pathologist with three separate automated methods to count % tumor nuclei on digital slides. “One of the most sought after applications in the field of digital imaging,” said Des Speed, CEO of PathXL.

The USCAP meeting will take place at the Hynes Convention Center in Boston (21st - 27th March) and attendees will have access to the exhibit hall from 21st - 25th March. You can find PathXL at booth 99 where you will also have the opportunity to meet our team of specialists offering live demonstrations of the TissueMark software.

Attending from PathXL are: John Durborow, Sales and Business Development Director for North America; Jonathon Tunstall, Director of Product Strategy and Don Ariyakumar, M.S, Technical Sales Specialist.

For more information on TissueMark visit its dedicated page or find us at USCAP exhibit hall Booth 99.

*Please note: TissueMark® is for research use only. Not for use in diagnostic procedures.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: PathXL

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Research articles,
CATCH Visitors via Your Competitors Announcements!


PathXL At USCAP - Official US Launch of Powerful Tumor Cell Counting Add-on for TissueMark

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

PathXL | TissueMark®
Publisher Contact: Press Office - PathXL.com 
+44(0)28 9073 8712 contact[.]pathxl.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any PathXL securities in any jurisdiction including any other companies listed or named in this release.

Research via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From PathXL / Company Profile


Read Research Most Recent Related Newswires:

DSM Announces Exclusive Partnership with Nanjing Cosmos Chemical Co., Ltd and Plans to Continue Expansion in UV Filters
DSM Launches New Enzyme Solutions At IFT17 to Improve Softness and Moistness of Gluten-free Bread
DSM and Evonik Select Nebraska for Production of Breakthrough Omega-3
Phasor to Develop Next Generation Electronically Steerable Antenna Featuring DSM Dyneema’s Advanced Radome Solution
DSM’s Delvotest® T Antibiotic Residue Test for Milk Validated by Finnish Food Safety Authority
Royal DSM to Make Equity Investment in Amyris with the Purpose of Establishing A Long-term Relationship
DSM Unveils New Beauty Active At NYSCC Suppliers’ Day
Iridea Bio - A New Sustainable Paint Made with DSM’s Decovery® Plant-based Resin
DSM to Showcase A Wide Range of Innovative Composite Solutions
DSM’s New Protective Delvo®Guard Cultures Reduce Food Waste in Dairy
DSM and Evonik Establish Joint Venture for Omega-3 Fatty Acids from Natural Marine Algae for Animal Nutrition
DSM Introduces Dyneema Purity® Black Fiber - The First Black Medical-grade UHMWPE Fiber
Research by German Wildau Technical University Confirms Long-term Performance of Dyneema® Soft Ballistics for Use in Bullet Resistant Vests
DSM Dyneema Wins Significant Patent Case in Israel
Actamax™ Submits IDE to FDA for Pivotal Study on Novel Sprayable Adhesion Barrier Device

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Rapid Recovery

Visit  MagLar, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)